MIR548K

gene
On this page

Also known as hsa-mir-548k

Summary

MIR548K (microRNA 548k, HGNC:35285) is a microRNA gene on chromosome 11q13.3.

microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop.

Source: NCBI Gene 100313770 — RefSeq curated summary.

At a glance

  • Gene type: non-coding (miRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:35285
Approved symbolMIR548K
NamemicroRNA 548k
Location11q13.3
Locus typeRNA, micro
StatusApproved
Aliaseshsa-mir-548k
Ensembl geneENSG00000221333
Ensembl biotypemiRNA
Entrez100313770
RNAcentralURS000075D3AD — ncRNA, 116 nt, 3 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 miRNA

ENST00000408406

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000408406 — 1 exons

ExonStartEnd
ENSE000015650417028395570284070

Expression profiles

Bgee: expression breadth broad, 76 present calls, max score 82.85.

Top tissues by expression

76 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
prefrontal cortexUBERON:000045182.85gold quality
calcaneal tendonUBERON:000370180.19gold quality
monocyteCL:000057677.16gold quality
bloodUBERON:000017876.72gold quality
stomachUBERON:000094575.79gold quality
corpus callosumUBERON:000233675.24gold quality
endometriumUBERON:000129573.99gold quality
adrenal tissueUBERON:001830372.58gold quality
gastrocnemiusUBERON:000138872.23gold quality
liverUBERON:000210772.05gold quality
tibial arteryUBERON:000761071.99gold quality
myometriumUBERON:000129671.50gold quality
bone marrowUBERON:000237171.26gold quality
kidneyUBERON:000211371.00gold quality
body of stomachUBERON:000116170.76gold quality
body of pancreasUBERON:000115070.21gold quality
colonUBERON:000115569.70gold quality
C1 segment of cervical spinal cordUBERON:000646969.70gold quality
body of uterusUBERON:000985369.58gold quality
heartUBERON:000094869.50gold quality
right lobe of liverUBERON:000111469.14gold quality
adult mammalian kidneyUBERON:000008269.10gold quality
adenohypophysisUBERON:000219668.83gold quality
heart left ventricleUBERON:000208468.59gold quality
transverse colonUBERON:000115768.35gold quality
intestineUBERON:000016068.25gold quality
esophagus mucosaUBERON:000246967.62gold quality
putamenUBERON:000187467.53gold quality
omental fat padUBERON:001041467.46gold quality
fundus of stomachUBERON:000116067.37gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.65

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 5)

  • miR-548k regulates the mRNA expression of its target gene CXCL13 in the thymus of myasthenia gravis patients with thymus hyperplasia and plays an important role in myasthenia gravis with thymus hyperplasia pathogenesis (PMID:29661539)
  • Study identified miR-548k as a promising biomarker for prognosis of esophageal squamous cell carcinoma (ESCC). MiR-548k was significantly upregulated in ESCC and associated with poor prognosis. Data further characterized SCNAs in ESCC and highlighted the crucial role of miR-548k in promoting lymphatic metastasis (PMID:30131072)
  • MicroRNA-548k upregulates a spliced variant of human CD2-associated protein by targeting its promoter. (PMID:32608582)
  • MiR-548k suppresses apoptosis in breast cancer cells by affecting PTEN/PI3K/AKT signaling pathway. (PMID:36309967)
  • ORAOV1, CCND1, and MIR548K Are the Driver Oncogenes of the 11q13 Amplicon in Squamous Cell Carcinoma. (PMID:37930255)

Cross-species orthologs

0 orthologs

Paralogs (25): MIR548AA1 (ENSG00000207704), MIR579 (ENSG00000207956), MIR548P (ENSG00000221263), MIR548F3 (ENSG00000221436), MIR548F1 (ENSG00000221594), MIR548N (ENSG00000221669), MIR548H3 (ENSG00000221698), MIR548AN (ENSG00000263515), MIR548X2 (ENSG00000263581), MIR548AX (ENSG00000263652), MIR548AS (ENSG00000263741), MIR548AV (ENSG00000263750), MIR548S (ENSG00000265056), MIR548AQ (ENSG00000265470), MIR548AG2 (ENSG00000265617), MIR548AJ1 (ENSG00000265669), MIR548AG1 (ENSG00000265829), MIR548X (ENSG00000265841), MIR548Z (ENSG00000266016), MIR548H5 (ENSG00000266807), MIR548AE1 (ENSG00000266808), MIR548O2 (ENSG00000275453), MIR548AY (ENSG00000276147), MIR548AZ (ENSG00000276479), MIR548AH (ENSG00000283682)

Protein

Non-coding RNA — no protein product; not a drug target.

Function

No curated pathway, Gene-Ontology, or interaction data.

Disease & clinical

No curated disease, variant, or cancer-driver associations.

Drugs & pharmacology

No drug or pharmacology data — not an established drug target.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.